Median Technologies (ALMDT) AI Stock Analysis

• Market Cap: €108.97M
• Dividend Yield: N/A
• Average Volume (3M): 465.96K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.30
• Revenue Growth: 6.75%
• EPS Growth: 15.48%
• Country: FR
• Employees: 225
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): -0.47
• Shares Outstanding: 36,658,386
• 10 Day Avg. Volume: 398,206
• 30 Day Avg. Volume: 465,957
• PEG Ratio: -0.29
• Price to Book (P/B): -2.06
• Price to Sales (P/S): 3.05
• P/FCF Ratio: -3.67
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €6.00
• Price Target Upside: 93.55% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: €3.00 ▼(-3.23% Downside)

The overall stock score is primarily impacted by the company's challenging financial performance, with significant losses and high leverage. While technical analysis shows some positive momentum, the negative valuation metrics further weigh down the score.

Positive Factors

Innovative Product Offering

Median Technologies' focus on AI-driven medical imaging solutions positions it well in the healthcare sector, offering durable competitive advantages and potential for long-term growth.

Partnerships and Revenue Opportunities

Collaborative partnerships expand revenue streams and enhance market reach, supporting sustainable growth and innovation in the company's offerings.

Revenue Growth

Positive revenue growth indicates increasing demand for the company's solutions, suggesting a strengthening market position and potential for continued expansion.

Negative Factors

Financial Instability

Negative equity and cash flow challenges highlight financial instability, potentially limiting the company's ability to invest in growth and innovation.

High Leverage

High leverage and negative equity suggest financial vulnerability, which could impact the company's long-term operational flexibility and risk profile.

Negative Profit Margins

Sustained negative profit margins indicate operational inefficiencies and challenges in achieving profitability, potentially affecting long-term business sustainability.

Median Technologies Business Overview & Revenue Model

Company Description

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California. The company was founded in 2002 and is based in Valbonne, France.

How the Company Makes Money

Median Technologies generates revenue primarily through the sale of its software solutions and services to healthcare providers, including hospitals and clinics. The company's revenue model includes licensing fees for its software, subscription fees for ongoing access to its services, and consulting fees for implementation and support. Additionally, Median often engages in partnerships with pharmaceutical companies and research institutions, which can lead to collaborative projects that provide further revenue opportunities. The company's focus on continuous innovation and integration of AI technology into its products also helps in maintaining a competitive edge, thus contributing to its earnings.

Median Technologies Financial Statement Overview

Summary

Median Technologies is facing significant financial challenges, with declining revenue and profitability, negative margins, and high leverage. The balance sheet shows negative equity, and cash flow issues further exacerbate the financial instability.

Income Statement

Median Technologies has faced declining revenue and profitability over recent years. Despite some growth in revenue from 2020 to 2024, the company has consistently reported negative gross and net profit margins. The EBIT and EBITDA margins are also negative, indicating operational challenges. The negative net income and declining revenue growth rate highlight ongoing financial struggles.

Balance Sheet

The company's balance sheet shows significant financial distress, with a negative stockholders' equity, indicating more liabilities than assets. The debt-to-equity ratio is not calculable due to negative equity, but the large amount of debt relative to assets points to high leverage. The equity ratio is negative, further underscoring financial instability.

Cash Flow

Median Technologies reports negative free cash flow, with a slight improvement in operating cash flow over recent years. The operating cash flow to net income ratio is negative, reflecting unsustainable operations. Free cash flow to net income is also negative, pointing to cash flow challenges that affect financial flexibility.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	23.31M	22.95M	22.23M	23.67M	20.55M	13.48M
Gross Profit	-17.89M	-21.07M	-2.55M	24.42M	20.43M	13.34M
EBITDA	-18.55M	-19.28M	-19.59M	-17.48M	-17.10M	-11.31M
Net Income	-21.99M	-25.24M	-22.98M	-20.21M	-19.29M	-12.80M
Balance Sheet
Total Assets	19.43M	24.37M	35.94M	34.75M	49.39M	25.28M
Cash, Cash Equivalents and Short-Term Investments	4.35M	8.29M	19.63M	21.67M	39.25M	16.40M
Total Debt	39.03M	29.44M	23.01M	18.15M	16.52M	15.66M
Total Liabilities	59.90M	58.34M	46.23M	42.01M	44.45M	36.65M
Stockholders Equity	-40.47M	-33.97M	-10.29M	-7.25M	4.94M	-11.36M
Cash Flow
Free Cash Flow	-14.95M	-19.03M	-21.53M	-17.18M	-10.61M	-5.82M
Operating Cash Flow	-13.89M	-17.95M	-20.24M	-15.79M	-10.13M	-5.46M
Investing Cash Flow	-799.00K	-1.17M	-1.25M	-1.39M	-672.00K	-327.00K
Financing Cash Flow	3.15M	7.67M	19.72M	-277.00K	33.20M	14.56M

Median Technologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3.10
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALMDT, the sentiment is Positive. The current price of 3.1 is above the 20-day moving average (MA) of 3.06, above the 50-day MA of 3.08, and above the 200-day MA of 2.57, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 52.37 is Neutral, neither overbought nor oversold. The STOCH value of 42.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:ALMDT.

Median Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ALMDT	48 Neutral	€108.97M	-2.55	―	―	6.75%	15.48%
AFME	48 Neutral	€62.53M	-4.24	-62.69%	―	―	30.04%
ALTHE	45 Neutral	$30.00M	―	-2351.12%	―	-4.70%	-64.31%
ALNOV	45 Neutral	$30.93M	―	-49.48%	―	5.10%	17.34%